E-LIB Suche - Ergebnisse für: Ferran Fece de la Cruz

1

Sotorasib Is a Pan-RASG12C Inhibitor Capable of Driving Cli..:

Rubinson, Douglas A. ; Tanaka, Noritaka ; Fece de la Cruz, Ferran...
Cancer Discovery. 14 (2024) 5 - p. 727-736 , 2024

Link: https://doi.org/10.1158/..

2

Allosteric PI3Kα Inhibition Overcomes On-target Resistance ..:

Varkaris, Andreas ; Fece de la Cruz, Ferran ; Martin, Elizabeth E....
Cancer Discovery. 14 (2023) 2 - p. 227-239 , 2023

Link: https://doi.org/10.1158/..

3

Landscape of Clinical Resistance Mechanisms to FGFR Inhibit..:

Wu, Qibiao ; Ellis, Haley ; Siravegna, Giulia...
Clinical Cancer Research. 30 (2023) 1 - p. 198-208 , 2023

Link: https://doi.org/10.1158/..

4

Epigenetic and transcriptional dysregulation of VWA2 associ..:

González, Beatriz ; Fece de la Cruz, Ferran ; Samuelsson, Johanna Kristina..
Scientific Reports. 8 (2018) 1 - p. , 2018

Link: https://doi.org/10.1038/..

5

MEK inhibitors block growth of lung tumours with mutations ..:

Smida, Michal ; Fece de la Cruz, Ferran ; Kerzendorfer, Claudia...
Nature Communications. 7 (2016) 1 - p. , 2016

Link: https://doi.org/10.1038/..

6

Synthetic Lethal Vulnerabilities of Cancer:

Fece de la Cruz, Ferran ; Gapp, Bianca V. ; Nijman, Sebastian M.B.
Annual Review of Pharmacology and Toxicology. 55 (2015) 1 - p. 513-531 , 2015

Link: https://doi.org/10.1146/..

7

Supplementary Figures S1 to S11 from Allosteric PI3Kα Inhib..:

Andreas Varkaris ; Ferran Fece de la Cruz ; Elizabeth E. Martin...
doi:10.1158/2159-8290.25183861.v1. , 2024

Link: https://doi.org/10.1158/..

8

Supplementary Figures S1 to S11 from Allosteric PI3Kα Inhib..:

Andreas Varkaris ; Ferran Fece de la Cruz ; Elizabeth E. Martin...
doi:10.1158/2159-8290.25191551.v1. , 2024

Link: https://doi.org/10.1158/..

9

Supplementary Figures S1 to S11 from Allosteric PI3Kα Inhib..:

Andreas Varkaris ; Ferran Fece de la Cruz ; Elizabeth E. Martin...
https://figshare.com/articles/journal_contribution/Supplementary_Figures_S1_to_S11_from_Allosteric_PI3K_Inhibition_Overcomes_On-target_Resistance_to_Orthosteric_Inhibitors_Mediated_by_Secondary_i_PIK3CA_i_Mutations/25183861. , 2024

Link: https://doi.org/10.1158/..

10

Supplementary Tables S1 to S5 from Allosteric PI3Kα Inhibit..:

Andreas Varkaris ; Ferran Fece de la Cruz ; Elizabeth E. Martin...
doi:10.1158/2159-8290.25191548.v1. , 2024

Link: https://doi.org/10.1158/..

11

Supplementary Tables S1 to S5 from Allosteric PI3Kα Inhibit..:

Andreas Varkaris ; Ferran Fece de la Cruz ; Elizabeth E. Martin...
https://figshare.com/articles/journal_contribution/Supplementary_Tables_S1_to_S5_from_Allosteric_PI3K_Inhibition_Overcomes_On-target_Resistance_to_Orthosteric_Inhibitors_Mediated_by_Secondary_i_PIK3CA_i_Mutations/25183858. , 2024

Link: https://doi.org/10.1158/..

12

Supplementary Tables S1 to S5 from Allosteric PI3Kα Inhibit..:

Andreas Varkaris ; Ferran Fece de la Cruz ; Elizabeth E. Martin...
doi:10.1158/2159-8290.25183858.v1. , 2024

Link: https://doi.org/10.1158/..

13

Supplementary Table S1 from Landscape of Clinical Resistanc..:

Qibiao Wu ; Haley Ellis ; Giulia Siravegna...
doi:10.1158/1078-0432.24947755.v1. , 2024

Link: https://doi.org/10.1158/..

14

Supplementary Figures S1 to S11 from Allosteric PI3Kα Inhib..:

Andreas Varkaris ; Ferran Fece de la Cruz ; Elizabeth E. Martin...
https://figshare.com/articles/journal_contribution/Supplementary_Figures_S1_to_S11_from_Allosteric_PI3K_Inhibition_Overcomes_On-target_Resistance_to_Orthosteric_Inhibitors_Mediated_by_Secondary_i_PIK3CA_i_Mutations/25191551. , 2024

Link: https://doi.org/10.1158/..

15

Supplementary Table S2 from Landscape of Clinical Resistanc..:

Qibiao Wu ; Haley Ellis ; Giulia Siravegna...
doi:10.1158/1078-0432.24947752.v1. , 2024

Link: https://doi.org/10.1158/..